| AP-1 | Activated protein-1 |
| ADCC | Antibody-dependent cell-mediated cytotoxicity |
| CAR-T | Chimeric antigen receptor T-cell |
| CTL | Cytotoxic T cells |
| CTLA-4 | Cytotoxic T lymphocyte-associated antigen-4 |
| CRS | Cytokine release syndrome |
| DC | Dendritic cells |
| DAMPs | Damage-associated molecular patterns |
| EMT | Epithelial-mesenchymal transition |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| GZMB | Granzyme B |
| PRF1 | Perforin 1 |
| IFNG | Interferon gamma |
| IL-2 | Interleukin-2 |
| IRAK1 | Interleukin-1 receptor-associated kinase 1 |
| CAFs | Cancer-associated fibroblasts |
| ST2L | Soluble ST2 (long form) |
| MAPK | Mitogen-activated protein kinase |
| TAK1 | Transforming growth factor-β-activated kinase 1 |
| CD8+ T cell | CD8-positive T cell |
| IRF | Interferon regulatory factor |
| IL-12 | Interleukin-12 |
| TRAP | TNF receptor-associated protein |
| RIP | Receptor-interacting protein |
| IL-18 | Interleukin-18 |
| IL-18Rs | IL-18 receptors |
| IL-18BP | IL-18-binding proteins |
| ICIs | Immune checkpoint inhibitors |
| IFN-γ | Interferon-γ |
| PBMC | Peripheral blood mononuclear cell |
| JNK | c-Jun endonucleotide-binding kinase |
| MDSCs | Myeloid-derived suppressor cells |
| MHC | Major histocompatibility complex |
| MMP-2 | Matrix metalloproteinase-2 |
| MMPs | Matrix metalloprMatrix metalloproteinasesoteinases |
| MyD88 | Myeloid differentiation factor 88 |
| NK | Natural killer |
| NF-κB | Nuclear factor-κB |
| PD-1 | Programmed death receptor-1 |
| IRAK-4 | Interleukin-1 Receptor-Associated Kinase |
| IRAK-1 | TRIF-related adaptor molecule |
| TRAM | Toll/Interleukin-1 Receptor domain |
| TIR | IκB Kinase |
| IKKα | IκB Kinase Alpha |
| IKKβ | IκB Kinase Beta |
| TAB1/2 | TAK1 Binding Protein 1/2 |
| IKKγ/NEMO | IκB Kinase Gamma |
| IκBα | Inhibitor of Nuclear Factor κB Alpha |
| PI3K | Phosphatidylinositol 3-kidronase |
| PD-L1 | Programmed cell death ligand-1 |
| PAMPs | Pathogen-associated molecular patterns |
| TRAF-6 | TNF-α receptor-associated factor-6 |
| TME | The tumor microenvironment |
| TAMs | Tumor-associated macrophages |
| TGF-β | Transforming growth factor-β |
| Tregs | Regulatory T cells |
| VEGF | Vascular endothelial growth factor |